Programme

Friday 14 June

07.00 – 08.00 Registration open
08.00 – 08.10 Welcome
08.10 – 09.25

 

 Session 1 – What makes myocardium arrhythmogenic?

  1. The role of the autonomic nervous system
  2. Genetics as major player
  3. Lessons learned from CMR
  4. AI will clarify
  5. Q&A panel
09.25 – 10.35 Session 2 – Leadless, wearable, extravascular, transvenous: Defibrillator update

  1. Dual-chamber leadless pacing and leadless pacemaker-defibrillator: Expectations and achievements
  2. Wearable cardioverter defibrillator – who, when and how long to bridge?
  3. Debate 1: Extravascular ICD will change the future of ICD
  4. Q&A panel
10.35 – 11.00 Coffee break
11. – 12.15 Session 3 – CSP or CRT: update 2024

  1. The human conduction system – What you need to know (including anatomical demonstrations
  2. Optimisation of CSP in heart failure – can we do better?
  3. Debate 2: CSP should replace CRT
  4. Q&A panel
12.15 – 13.15 Lunch break
13.15 – 14.30 Session 4 – Channelopathies: State of the art diagnostic and treatment

  1. Provocation tests and PES – when and how to use in PED.
  2. Brugada syndrome – drugs or ablation or wait, and see
  3. LQT – from gene specific drug treatment to interventional treatment
  4. CPVT – acute and long-term management
  5. Q&A panel
14.30 – 15.15 Session 5 – Young EP arena I
15.15 – 15.40 Coffee break
15.40 – 17.00 Session 6 – VT management: update on trials and registraties

  1. PROFID: a game changer?
  2. PROTECT – TOF: a multicentre registry.
  3. Does early VT ablation improve outcome?
  4. Survival of ICD patients in 2024 – data from a Czech nationwide registry.
  5. Impact of optimized heart failure treatment on VA – what is the evidence?
  6. Q&A panel
18.15 Reception for all participants

Saturday 15 June

07.30 – 08.00 Registration open
08.00 – 09.15 Session 7 – PVCs: evaluation, ablation and outcome

  1. Patients with PVCs – what diagnostics do we need, what can we spare?
  2. What do we need to have in the box if we address patients with a low PVC burden?
  3. What is your mapping and ablation strategy for PVCs from the Outflow tracts? Simultaneous anatomical demonstrations on human specimen.
  4. What is your mapping and ablation strategy for PVC from unique sites. Simultaneous anatomical demonstrations on human specimen.
  5. Q&A panel
09.15 – 10.15 Session 8 – Live in the Box

  1. Coronary venous mapping step by step
  2. Venous alcohol ablation in structural heart disease
  3. Needle mapping and ablation
  4. Q&A panel
10.15 – 10.45 Coffee break
10.45 – 12.00 Session 9 – Approaches to VT substrates – hype or reality in 2024?

  1. Imaging guided ablation
  2. PFA and large footprint catheters (RF/PFA)
  3. Stereotactic radiotherapy
  4. Epicardial approach: homogeneous indications?
  5. Q&A panel
12.00 – 13.00 Session 10 – Young EP arena II
13.00 – 14.00 Lunch break
14.00 – 15.30 Session 11 – Mapping and ablation: What do we have and what is needed? Session I

  1. You need to know the basics: Electrogram recordings and filter settings
  2. Bipolar and unipolar Electrograms – Value, field of view, limitations and learning to use the slider bar
  3. Multi electrode catheter mapping: Grid, multiple splines, linear electrodes, bipolar or omnipolar – what to choose and when?
  4. Pearls and Pitfalls of Pace-mapping
  5. How to perform and Interpret Entrainment mapping
  6. Q&A panel
15.30 – 16.45 Session 12 – Mapping and ablation: What do we have and what is needed? Session II

  1. Functional substrate mapping – ILAM, EDP and DEEP
  2. Layered epicardial and intramural substrate in NICM – recognition and ablation options
  3. VF – VPD trigger and Substrate mapping – which patients, where to find, best provocation techniques and endpoints?
  4. Complications of VT ablation – How to recognize, how to avoid?
  5. Q&A panel
16.45 Adjourn